Selected research
Industry Research
Heparin API Industry Research Report 2026
Market perspective
The global Heparin API market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Heparin API is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Heparin API is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Heparin API is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Heparin API include Bioibérica, Opocrin, Hebei Changshan Biochemical Pharmaceutical, Cisen Pharmaceutical, Sichuan Deebio Pharmaceutical, Yantai Dongcheng Pharmaceutical, Dongying Tiandong Pharmaceutical, Shenzhen Hepalink Pharmaceutical and Hubei Enoray Biopharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Heparin API market in terms of revenue (US$ million) and, where applicable, sales volume (b units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/b units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Heparin API Market by Company
Bioibérica
Opocrin
Hebei Changshan Biochemical Pharmaceutical
Cisen Pharmaceutical
Sichuan Deebio Pharmaceutical
Yantai Dongcheng Pharmaceutical
Dongying Tiandong Pharmaceutical
Shenzhen Hepalink Pharmaceutical
Hubei Enoray Biopharmaceutical
Pfizer
Nanjing King-friend Biochemical Pharmaceutical
Qingdao Jiulong Biopharmaceutical
Changzhou Qianhong Biopharma
Nanjing Xinbai Pharmaceutical
Yino Pharma
Heparin API Segment by Type
Heparin Sodium
Heparin Calcium
Heparin API Segment by Application
UFH
LMWH
Heparin API Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Heparin API market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Heparin API and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Heparin API.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Heparin API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Heparin API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Heparin API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Heparin Sodium
- Heparin Calcium
Applications
- UFH
- LMWH
Companies covered
- Bioibérica
- Opocrin
- Hebei Changshan Biochemical Pharmaceutical
- Cisen Pharmaceutical
- Sichuan Deebio Pharmaceutical
- Yantai Dongcheng Pharmaceutical
- Dongying Tiandong Pharmaceutical
- Shenzhen Hepalink Pharmaceutical
- Hubei Enoray Biopharmaceutical
- Pfizer
- Nanjing King-friend Biochemical Pharmaceutical
- Qingdao Jiulong Biopharmaceutical
- Changzhou Qianhong Biopharma
- Nanjing Xinbai Pharmaceutical
- Yino Pharma
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Heparin API Market Size (2021-2032)
- 2.2.2 Global Heparin API Sales (2021-2032)
- 2.2.3 Global Heparin API Market Average Price (2021-2032)
- 2.3 Heparin API by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Heparin Sodium
- 2.3.3 Heparin Calcium
- 2.4 Heparin API by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 UFH
- 2.4.3 LMWH
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Heparin API Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Heparin API Sales (b units) of Manufacturers (2021-2026)
- 3.3 Global Heparin API Revenue of Manufacturers (2021-2026)
- 3.4 Global Heparin API Average Price by Manufacturers (2021-2026)
- 3.5 Global Heparin API Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Heparin API, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Heparin API, Product Type & Application
- 3.8 Global Manufacturers of Heparin API, Established Date
- 3.9 Global Heparin API Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Bioibérica
- 4.1.1 Bioibérica Company Information
- 4.1.2 Bioibérica Business Overview
- 4.1.3 Bioibérica Heparin API Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Bioibérica Heparin API Product Portfolio
- 4.1.5 Bioibérica Recent Developments
- 4.2 Opocrin
- 4.2.1 Opocrin Company Information
- 4.2.2 Opocrin Business Overview
- 4.2.3 Opocrin Heparin API Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Opocrin Heparin API Product Portfolio
- 4.2.5 Opocrin Recent Developments
- 4.3 Hebei Changshan Biochemical Pharmaceutical
- 4.3.1 Hebei Changshan Biochemical Pharmaceutical Company Information
- 4.3.2 Hebei Changshan Biochemical Pharmaceutical Business Overview
- 4.3.3 Hebei Changshan Biochemical Pharmaceutical Heparin API Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Hebei Changshan Biochemical Pharmaceutical Heparin API Product Portfolio
- 4.3.5 Hebei Changshan Biochemical Pharmaceutical Recent Developments
- 4.4 Cisen Pharmaceutical
- 4.4.1 Cisen Pharmaceutical Company Information
- 4.4.2 Cisen Pharmaceutical Business Overview
- 4.4.3 Cisen Pharmaceutical Heparin API Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Cisen Pharmaceutical Heparin API Product Portfolio
- 4.4.5 Cisen Pharmaceutical Recent Developments
- 4.5 Sichuan Deebio Pharmaceutical
- 4.5.1 Sichuan Deebio Pharmaceutical Company Information
- 4.5.2 Sichuan Deebio Pharmaceutical Business Overview
- 4.5.3 Sichuan Deebio Pharmaceutical Heparin API Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Sichuan Deebio Pharmaceutical Heparin API Product Portfolio
- 4.5.5 Sichuan Deebio Pharmaceutical Recent Developments
- 4.6 Yantai Dongcheng Pharmaceutical
- 4.6.1 Yantai Dongcheng Pharmaceutical Company Information
- 4.6.2 Yantai Dongcheng Pharmaceutical Business Overview
- 4.6.3 Yantai Dongcheng Pharmaceutical Heparin API Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Yantai Dongcheng Pharmaceutical Heparin API Product Portfolio
- 4.6.5 Yantai Dongcheng Pharmaceutical Recent Developments
- 4.7 Dongying Tiandong Pharmaceutical
- 4.7.1 Dongying Tiandong Pharmaceutical Company Information
- 4.7.2 Dongying Tiandong Pharmaceutical Business Overview
- 4.7.3 Dongying Tiandong Pharmaceutical Heparin API Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Dongying Tiandong Pharmaceutical Heparin API Product Portfolio
- 4.7.5 Dongying Tiandong Pharmaceutical Recent Developments
- 4.8 Shenzhen Hepalink Pharmaceutical
- 4.8.1 Shenzhen Hepalink Pharmaceutical Company Information
- 4.8.2 Shenzhen Hepalink Pharmaceutical Business Overview
- 4.8.3 Shenzhen Hepalink Pharmaceutical Heparin API Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Shenzhen Hepalink Pharmaceutical Heparin API Product Portfolio
- 4.8.5 Shenzhen Hepalink Pharmaceutical Recent Developments
- 4.9 Hubei Enoray Biopharmaceutical
- 4.9.1 Hubei Enoray Biopharmaceutical Company Information
- 4.9.2 Hubei Enoray Biopharmaceutical Business Overview
- 4.9.3 Hubei Enoray Biopharmaceutical Heparin API Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Hubei Enoray Biopharmaceutical Heparin API Product Portfolio
- 4.9.5 Hubei Enoray Biopharmaceutical Recent Developments
- 4.10 Pfizer
- 4.10.1 Pfizer Company Information
- 4.10.2 Pfizer Business Overview
- 4.10.3 Pfizer Heparin API Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Pfizer Heparin API Product Portfolio
- 4.10.5 Pfizer Recent Developments
- 4.11 Nanjing King-friend Biochemical Pharmaceutical
- 4.11.1 Nanjing King-friend Biochemical Pharmaceutical Company Information
- 4.11.2 Nanjing King-friend Biochemical Pharmaceutical Business Overview
- 4.11.3 Nanjing King-friend Biochemical Pharmaceutical Heparin API Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Nanjing King-friend Biochemical Pharmaceutical Heparin API Product Portfolio
- 4.11.5 Nanjing King-friend Biochemical Pharmaceutical Recent Developments
- 4.12 Qingdao Jiulong Biopharmaceutical
- 4.12.1 Qingdao Jiulong Biopharmaceutical Company Information
- 4.12.2 Qingdao Jiulong Biopharmaceutical Business Overview
- 4.12.3 Qingdao Jiulong Biopharmaceutical Heparin API Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Qingdao Jiulong Biopharmaceutical Heparin API Product Portfolio
- 4.12.5 Qingdao Jiulong Biopharmaceutical Recent Developments
- 4.13 Changzhou Qianhong Biopharma
- 4.13.1 Changzhou Qianhong Biopharma Company Information
- 4.13.2 Changzhou Qianhong Biopharma Business Overview
- 4.13.3 Changzhou Qianhong Biopharma Heparin API Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Changzhou Qianhong Biopharma Heparin API Product Portfolio
- 4.13.5 Changzhou Qianhong Biopharma Recent Developments
- 4.14 Nanjing Xinbai Pharmaceutical
- 4.14.1 Nanjing Xinbai Pharmaceutical Company Information
- 4.14.2 Nanjing Xinbai Pharmaceutical Business Overview
- 4.14.3 Nanjing Xinbai Pharmaceutical Heparin API Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Nanjing Xinbai Pharmaceutical Heparin API Product Portfolio
- 4.14.5 Nanjing Xinbai Pharmaceutical Recent Developments
- 4.15 Yino Pharma
- 4.15.1 Yino Pharma Company Information
- 4.15.2 Yino Pharma Business Overview
- 4.15.3 Yino Pharma Heparin API Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 Yino Pharma Heparin API Product Portfolio
- 4.15.5 Yino Pharma Recent Developments
5 Global Heparin API Market Scenario by Region
- 5.1 Global Heparin API Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Heparin API Sales by Region: 2021-2032
- 5.2.1 Global Heparin API Sales by Region: 2021-2026
- 5.2.2 Global Heparin API Sales by Region: 2027-2032
- 5.3 Global Heparin API Revenue by Region: 2021-2032
- 5.3.1 Global Heparin API Revenue by Region: 2021-2026
- 5.3.2 Global Heparin API Revenue by Region: 2027-2032
- 5.4 North America Heparin API Market Facts & Figures by Country
- 5.4.1 North America Heparin API Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Heparin API Sales by Country (2021-2032)
- 5.4.3 North America Heparin API Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Heparin API Market Facts & Figures by Country
- 5.5.1 Europe Heparin API Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Heparin API Sales by Country (2021-2032)
- 5.5.3 Europe Heparin API Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Heparin API Market Facts & Figures by Country
- 5.6.1 Asia Pacific Heparin API Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Heparin API Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Heparin API Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Heparin API Market Facts & Figures by Country
- 5.7.1 South America Heparin API Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Heparin API Sales by Country (2021-2032)
- 5.7.3 South America Heparin API Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Heparin API Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Heparin API Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Heparin API Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Heparin API Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Heparin API Sales by Type (2021-2032)
- 6.1.1 Global Heparin API Sales by Type (2021-2032) & (b units)
- 6.1.2 Global Heparin API Sales Market Share by Type (2021-2032)
- 6.2 Global Heparin API Revenue by Type (2021-2032)
- 6.2.1 Global Heparin API Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Heparin API Revenue Market Share by Type (2021-2032)
- 6.3 Global Heparin API Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Heparin API Sales by Application (2021-2032)
- 7.1.1 Global Heparin API Sales by Application (2021-2032) & (b units)
- 7.1.2 Global Heparin API Sales Market Share by Application (2021-2032)
- 7.2 Global Heparin API Revenue by Application (2021-2032)
- 7.2.1 Global Heparin API Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Heparin API Revenue Market Share by Application (2021-2032)
- 7.3 Global Heparin API Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Heparin API Value Chain Analysis
- 8.1.1 Heparin API Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Heparin API Production Mode & Process
- 8.2 Heparin API Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Heparin API Distributors
- 8.2.3 Heparin API Customers
9 Global Heparin API Analyzing Market Dynamics
- 9.1 Heparin API Industry Trends
- 9.2 Heparin API Industry Drivers
- 9.3 Heparin API Industry Opportunities and Challenges
- 9.4 Heparin API Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst